By Professor Caroline Ford

Conference Abstracts

Liu D; Gunther K; Daniels B; O'Mara T; Tang K; Ford C, 2020, 'ROR1: A novel target in endometrial cancer', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, ELECTR NETWORK, Vol. 80, presented at AACR Annual Meeting, ELECTR NETWORK, 22 June 2020 - 24 June 2020, http://dx.doi.org/10.1158/1538-7445.AM2020-2942

Liu D; John M; Henry CE; Christie EL; Bowtell DDL; Tang K; Heinzelmann-Schwarz V; Kennedy C; Boros J; DeFazio A; Ford CE, 2019, 'ROR1 is associated with ovarian cancer progression and chemoresistance.', in CLINICAL CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, GA, Atlanta, Vol. 26, pp. 59 - 60, presented at AACR Special Conference on Advances in Ovarian Cancer Research, GA, Atlanta, 13 September 2019 - 16 September 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000546013300077&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Media

Ford C; Chisholm O, 2015, Brace yourself genetic testing might give you more than you bargained for., , https://theconversation.com/brace-yourself-genetic-testing-might-give-you-more-than-you-bargained-for-40246

Preprints

Werner B; Powell E; Duggan J; Cortesi M; Lee YC; Arora V; Athavale R; Dean M; Warton K; Ford C, 2024, Cell-free DNA from ascites identifies clinically relevant variants and tumour evolution in patients with advanced ovarian cancer, , http://dx.doi.org/10.1101/2024.03.09.24303840

Cortesi M; Liu D; Powell E; Barlow E; Warton K; Ford C, 2023, Accurate identification of cancer cells in complex pre-clinical models using deep-learning: a transfection-free approach, , http://dx.doi.org/10.1101/2023.10.15.562411

Phan Z; Ford C; Caldon E, 2023, DNA repair biomarkers to guide usage of combined PARP inhibitors and chemotherapy: a meta-analysis and systematic review, , http://dx.doi.org/10.1101/2023.05.24.23290442

Cortesi M; Liu D; Yee C; Marsh D; Ford C, 2023, Model Parameter identification using 2D vs 3D experimental data: a comparative analysis, , http://dx.doi.org/10.1101/2023.05.17.541071

John M; Ford C, 2021, Pan-tissue and -cancer analysis of ROR1 and ROR2 transcript variants identify novel functional significance for an alternative splice variant of ROR1, , http://dx.doi.org/10.1101/2021.11.24.469652

John M; Rao P; Noor H; Ford C, 2021, ROR1 is a novel putative druggable target for diffuse glioma, , http://dx.doi.org/10.1101/2021.12.03.21267166

Back to profile page